Patent Application: Complex for Cartilage Differentiation
Summary
The USPTO has published a new patent application (US20260083780A1) detailing a complex for promoting cartilage differentiation. The application describes a method for fabricating cartilage and a pharmaceutical composition for treating arthropathy, filed on June 2, 2025.
What changed
This document is a publication of a new patent application filed with the USPTO, specifically application number US20260083780A1. The application, titled 'Complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, and use thereof,' was filed on June 2, 2025. It describes a complex intended to promote cartilage differentiation, a method for fabricating cartilage using this complex, and a pharmaceutical composition for preventing or treating arthropathy.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the biotechnology and healthcare sectors related to cartilage regeneration and arthropathy treatment. Companies operating in these areas may wish to monitor the progress of this patent application and related intellectual property.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF
Application US20260083780A1 Kind: A1 Mar 26, 2026
Inventors
Kyung Sun Kang, Seung Hee Lee, Jong Chan Ahn, Mi Jin Kim
Abstract
The present invention relates to a complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, a method for fabricating cartilage by using the complex, cartilage fabricated via the method, a pharmaceutical composition comprising the complex for preventing or treating arthropathy, a method for preventing or treating arthropathy using the composition, a composition for inducing cartilage cell differentiation comprising the prepared cartilage cells, and a method for fabricating cartilage using the prepared cartilage cells. The complex for promoting cartilage differentiation comprising the stem cells or the culture thereof and the cartilage cell-free crush provided in the present invention is not only differentiated into cartilage cells without side effects even in vivo, but also promotes differentiation of inherent stem cells in vivo into cartilage cells via a paracrine effect exhibited in the differentiated cartilage cells to effectively regenerate the damaged cartilage, and thus the complex may be widely used for treatment of arthropathy involving the cartilage damage.
CPC Classifications
A61K 35/32 A61K 35/51 A61K 35/545 C12N 5/0655 C12N 5/0665 C12N 2506/1369
Filing Date
2025-06-02
Application No.
19225491
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.